Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Therapeutic Drug Carrier Systems
Fator do impacto: 2.9 FI de cinco anos: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X

Volumes:
Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i1.10
pages 1-26

Therapy Considerations in Drug-Eluting Stents

Jeffrey T. Ellis
Deborah L. Kilpatrick
Paul Macke Consigny
Department of Radiology, Suite 4200 Gibbon, Thomas Jefferson University Hospital, Thomas Jefferson University, 111 South 11th St., Philadelphia, PA 19107; and Department of Physiology, Jefferson Medical College, Philadelphia, PA 19107
Santosh Prabhu
Syed F. A. Hossainy
Guidant Corporation, 3200 Lakeside Drive, Mailstop S-238, Santa Clara CA 95054-2807, USA

RESUMO

Approximately 12 million Americans have coronary artery disease, and almost one in five deaths in the United States can be attributed to this disease. In addition, 1.2 million Americans undergo cardiac catheterization and over one-half million receive a percutaneous coronary intervention such as balloon angioplasty, atherectomy, or stent implantation annually. This article will provide an overview of (1) atherosclerosis, the progressive disease which can lead to thrombotic events and/or the development of hemodynamically significant coronary artery lesions; (2) restenosis, the reappearance of significant lesions after coronary interventions such as stent placement; and (3) drugeluting stents, the devices which, by using appropriate polymers to elute the appropriate drug with the appropriate pharmacokinetics, have almost completely eliminated restenosis.


Articles with similar content:

Thirty-Day Readmission Rates Comparing Specific Cruciate Retaining and Posterior Stabilizing Knee Arthroplasties to the National Readmission Rates
Journal of Long-Term Effects of Medical Implants, Vol.25, 2015, issue 4
Todd P. Pierce, Julio J. Jauregui, Jeffery J. Cherian, Michael A. Mont, Randa K Elmallah
Long-Term Complications of Mesh Repairs for Abdominal-Wall Hernias
Journal of Long-Term Effects of Medical Implants, Vol.21, 2011, issue 3
Duray Seker, Hakan Kulacoglu
Cholelithiasis and Cholecystitis
Journal of Long-Term Effects of Medical Implants, Vol.15, 2005, issue 3
Richard Edlich, Bruce D. Schirmer, Kathryne L. Winters
Diffusion Tensor Imaging of Tendons and Ligaments at Ultra-High Magnetic Fields
Critical Reviews™ in Biomedical Engineering, Vol.46, 2018, issue 4
Weiguo Li, Aman Gupta, Richard L. Magin, Martina Guidetti, Marco Andrea Zampini, Vincent M. Wang, Giulia Gandini
Vascular complications in orthopaedic surgery
Journal of Long-Term Effects of Medical Implants, Vol.21, 2011, issue 2
Milva Battaglia, Andrea Angelini, Andreas F. Mavrogenis, Eugenio Rimondi, Pietro Ruggieri, Giuseppe Rossi